Leaflet ZENADEA 2mg / 0.03mg film-coated tablets
Indicated for: contraception
Route of administration: oral
Substance: dienogest + ethinylestradiol (progestogen + estrogen)
ATC: G03AA16 (Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
The combination of dienogest and ethinylestradiol is used as an oral contraceptive to prevent pregnancy. Dienogest is a progestin, and ethinylestradiol is an estrogen, both working to inhibit ovulation and alter the uterine lining.
The medication is taken orally, usually once daily at the same time, following a 21- or 28-day cycle. It is important to adhere to the administration schedule to ensure contraceptive effectiveness.
Side effects may include nausea, headaches, breast tenderness, or mood changes. In rare cases, severe reactions such as venous thromboembolism may occur.
This combination is not recommended for pregnant women, breastfeeding mothers, or patients with a history of thrombosis, severe liver disease, or hypersensitivity to any of the components.
General data about ZENADEA 2mg / 0.03mg
- Substance: dienogest + ethinylestradiol
- Date of latest medicines list: 01-03-2022
- Product code: W57836001
- Concentration: 2mg / 0.03mg
- Pharmaceutical form: film-coated tablets
- Quantity: 21
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.